advertisement

WGA Rescources

49

Showing records 1 to 25 | Display all abstracts from

84577 Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year After Pediatric Lensectomy
Freedman SF
JAMA ophthalmology 2019; 0:
85121 Consultation Section: Glaucoma. Cataract, glaucoma, possible Marfan syndrome, and conception aspirations

Journal of Cataract and Refractive Surgery 2020; 46: 154-161
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
King AJ
American Journal of Ophthalmology 2020; 213: 186-194
84987 Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium
Tham YC
British Journal of Ophthalmology 2020; 0:
84946 Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients' Experiences, Preferences, and Values

Ontario health technology assessment series 2019; 19: 1-57
84968 Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom
Khawaja AP
Ophthalmology 2020; 127: 748-757
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Craven ER
Drugs 2020; 80: 167-179
84987 Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium
Tao Y
British Journal of Ophthalmology 2020; 0:
84577 Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year After Pediatric Lensectomy
Kraker RT
JAMA ophthalmology 2019; 0:
84968 Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom
Campbell JH
Ophthalmology 2020; 127: 748-757
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Walters T
Drugs 2020; 80: 167-179
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Hudson J; Fernie G
American Journal of Ophthalmology 2020; 213: 186-194
84987 Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium
Zhang L
British Journal of Ophthalmology 2020; 0:
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Christie WC
Drugs 2020; 80: 167-179
84577 Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year After Pediatric Lensectomy
Repka MX
JAMA ophthalmology 2019; 0:
84968 Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom
Kirby N
Ophthalmology 2020; 127: 748-757
84987 Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium
Rim THT
British Journal of Ophthalmology 2020; 0:
84577 Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year After Pediatric Lensectomy
Wallace DK
JAMA ophthalmology 2019; 0:
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Day DG
Drugs 2020; 80: 167-179
84968 Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom
Chandwani HS
Ophthalmology 2020; 127: 748-757
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Burr J; Azuara-Blanco A
American Journal of Ophthalmology 2020; 213: 186-194
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Lewis RA
Drugs 2020; 80: 167-179
84987 Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium
Thakur S
British Journal of Ophthalmology 2020; 0:
84577 Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year After Pediatric Lensectomy
De Alba Campomanes A
JAMA ophthalmology 2019; 0:
84968 Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom
Keyzor I
Ophthalmology 2020; 127: 748-757

Issue 21-1

Change Issue


advertisement

Oculus